1. Home
  2. GDDY vs RDY Comparison

GDDY vs RDY Comparison

Compare GDDY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoDaddy Inc.

GDDY

GoDaddy Inc.

HOLD

Current Price

$103.83

Market Cap

11.0B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$11.91

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDDY
RDY
Founded
1997
1984
Country
United States
India
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
9.9B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
GDDY
RDY
Price
$103.83
$11.91
Analyst Decision
Buy
Strong Buy
Analyst Count
16
1
Target Price
$136.44
$16.90
AVG Volume (30 Days)
1.6M
2.1M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
N/A
EPS
3.43
N/A
Revenue
N/A
N/A
Revenue This Year
$7.94
$7.72
Revenue Next Year
$6.10
$3.50
P/E Ratio
$28.59
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$71.59
$11.36
52 Week High
$148.19
$15.67

Technical Indicators

Market Signals
Indicator
GDDY
RDY
Relative Strength Index (RSI) 56.28 42.12
Support Level $81.16 $11.58
Resistance Level $101.99 $12.38
Average True Range (ATR) 3.30 0.16
MACD -0.28 -0.01
Stochastic Oscillator 63.82 37.59

Price Performance

Historical Comparison
GDDY
RDY

About GDDY GoDaddy Inc.

GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: